Copyright 2026 BBC. All rights reserved. The BBC is not responsible for the content of external sites. Read about our approach to external linking.

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by ...

Cama and Albless Hospital opens a palliative care centre for cancer patients while planning brachytherapy treatment to ...

Genitourinary (GU) cancers, including prostate, bladder, renal and testicular malignancies, represent a heterogeneous group of diseases with varying ...

The Oscar-winning US actor whose roles ranged from 1980s dramas to Marvel films, died at the age of 71 in March 2022. In a statement released at the time of his death, his loved ones confirmed he died ...

A global phase 3 trial enrolled mHSPC with ≥90% PTEN loss by IHC and randomized 1,012 patients to intermittent capivasertib plus abiraterone/prednisone versus ...

Healthcare professionals discuss the challenges of staff turnover and the importance of communication and systematic notes to ensure patient safety. This episode, titled ‘Workflow in Advanced Prostate ...

Final overall survival data for PEACE-3 (NCT02194842) evaluating the combination of enzalutamide (Xtandi) and radium-223 (Xofigo) will be presented at the 2026 ASCO GU Cancers Symposium. In an ...

PROSTOX Standard targets CFRT (37–45 fractions) and MHFRT (20–28 fractions), expanding a regimen-specific platform aimed at predicting late GU toxicity after EBRT in localized prostate cancer.

Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center ...

ADT with injectable gonadotropin-releasing hormone (GnRH) receptor agonists such as leuprolide has been associated with cardiovascular morbidity, and cardiovascular disease is the leading cause of ...

Bone-protecting therapies are an important part of delivering optimal care in patients with prostate cancer who are treated with androgen-deprivation therapy. Rahul Parikh, MD, a professor of medicine ...